1. Home
  2. IVDA vs PMCB Comparison

IVDA vs PMCB Comparison

Compare IVDA & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iveda Solutions Inc.

IVDA

Iveda Solutions Inc.

HOLD

Current Price

$0.88

Market Cap

4.5M

Sector

Technology

ML Signal

HOLD

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.94

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IVDA
PMCB
Founded
2003
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
5.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IVDA
PMCB
Price
$0.88
$0.94
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.2M
9.9M
Earning Date
11-14-2025
12-15-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.01
Revenue
$6,395,926.00
N/A
Revenue This Year
$340.48
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$162.06
Revenue Growth
20.56
N/A
52 Week Low
$0.61
$0.63
52 Week High
$8.05
$1.90

Technical Indicators

Market Signals
Indicator
IVDA
PMCB
Relative Strength Index (RSI) 41.04 50.52
Support Level $1.11 $0.71
Resistance Level $1.37 $1.51
Average True Range (ATR) 0.16 0.20
MACD -0.01 0.02
Stochastic Oscillator 10.59 33.08

Price Performance

Historical Comparison
IVDA
PMCB

About IVDA Iveda Solutions Inc.

Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

Share on Social Networks: